These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27475894)

  • 21. Bone morphogenetic protein receptor type 2 mutations, clinical phenotypes and outcomes of Japanese patients with sporadic or familial pulmonary hypertension.
    Kabata H; Satoh T; Kataoka M; Tamura Y; Ono T; Yamamoto M; Huqun ; Hagiwara K; Fukuda K; Betsuyaku T; Asano K
    Respirology; 2013 Oct; 18(7):1076-82. PubMed ID: 23675998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased susceptibility to hypoxic pulmonary hypertension in Bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature.
    Frank DB; Lowery J; Anderson L; Brink M; Reese J; de Caestecker M
    Am J Physiol Lung Cell Mol Physiol; 2008 Jan; 294(1):L98-109. PubMed ID: 18024717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of
    Theobald V; Benjamin N; Seyfarth HJ; Halank M; Schneider MA; Richtmann S; Hinderhofer K; Xanthouli P; Egenlauf B; Seeger R; Hoeper MM; Jonigk D; Grünig E; Eichstaedt CA
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627145
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
    Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
    Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary vascular response patterns during exercise in interstitial lung disease.
    Degani-Costa LH; Levarge B; Digumarthy SR; Eisman AS; Harris RS; Lewis GD
    Eur Respir J; 2015 Sep; 46(3):738-49. PubMed ID: 25976688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RV contractility and exercise-induced pulmonary hypertension in chronic mountain sickness: a stress echocardiographic and tissue Doppler imaging study.
    Pratali L; Allemann Y; Rimoldi SF; Faita F; Hutter D; Rexhaj E; Brenner R; Bailey DM; Sartori C; Salmon CS; Villena M; Scherrer U; Picano E; Sicari R
    JACC Cardiovasc Imaging; 2013 Dec; 6(12):1287-97. PubMed ID: 24269266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AntagomiR directed against miR-20a restores functional BMPR2 signalling and prevents vascular remodelling in hypoxia-induced pulmonary hypertension.
    Brock M; Samillan VJ; Trenkmann M; Schwarzwald C; Ulrich S; Gay RE; Gassmann M; Ostergaard L; Gay S; Speich R; Huber LC
    Eur Heart J; 2014 Dec; 35(45):3203-11. PubMed ID: 22450430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in Diastolic Heart Failure (RELAX) Trial.
    Hussain I; Mohammed SF; Forfia PR; Lewis GD; Borlaug BA; Gallup DS; Redfield MM
    Circ Heart Fail; 2016 Apr; 9(4):e002729. PubMed ID: 27072860
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel mutations in BMPR2, ACVRL1 and KCNA5 genes and hemodynamic parameters in patients with pulmonary arterial hypertension.
    Pousada G; Baloira A; Vilariño C; Cifrian JM; Valverde D
    PLoS One; 2014; 9(6):e100261. PubMed ID: 24936649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension.
    Phillips JA; Poling JS; Phillips CA; Stanton KC; Austin ED; Cogan JD; Wheeler L; Yu C; Newman JH; Dietz HC; Loyd JE
    Genet Med; 2008 May; 10(5):359-65. PubMed ID: 18496036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of sildenafil on the human response to acute hypoxia and exercise.
    Ricart A; Maristany J; Fort N; Leal C; Pagés T; Viscor G
    High Alt Med Biol; 2005; 6(1):43-9. PubMed ID: 15772499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional magnetic resonance imaging for in vivo quantification of pulmonary hypertension in the Sugen 5416/hypoxia mouse.
    Breen EC; Scadeng M; Lai NC; Murray F; Bigby TD
    Exp Physiol; 2017 Mar; 102(3):347-353. PubMed ID: 27897352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BMPR2 mutation status influences bronchial vascular changes in pulmonary arterial hypertension.
    Ghigna MR; Guignabert C; Montani D; Girerd B; Jaïs X; Savale L; Hervé P; Thomas de Montpréville V; Mercier O; Sitbon O; Soubrier F; Fadel E; Simonneau G; Humbert M; Dorfmüller P
    Eur Respir J; 2016 Dec; 48(6):1668-1681. PubMed ID: 27811071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RV dysfunction in pulmonary hypertension is independently related to pulmonary artery stiffness.
    Stevens GR; Garcia-Alvarez A; Sahni S; Garcia MJ; Fuster V; Sanz J
    JACC Cardiovasc Imaging; 2012 Apr; 5(4):378-87. PubMed ID: 22498327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension.
    Hemnes AR; Brittain EL; Trammell AW; Fessel JP; Austin ED; Penner N; Maynard KB; Gleaves L; Talati M; Absi T; Disalvo T; West J
    Am J Respir Crit Care Med; 2014 Feb; 189(3):325-34. PubMed ID: 24274756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation.
    Girerd B; Montani D; Coulet F; Sztrymf B; Yaici A; Jaïs X; Tregouet D; Reis A; Drouin-Garraud V; Fraisse A; Sitbon O; O'Callaghan DS; Simonneau G; Soubrier F; Humbert M
    Am J Respir Crit Care Med; 2010 Apr; 181(8):851-61. PubMed ID: 20056902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of Vascular Distensibility During Exercise Is an Early Hemodynamic Marker of Pulmonary Vascular Disease.
    Lau EMT; Chemla D; Godinas L; Zhu K; Sitbon O; Savale L; Montani D; Jaïs X; Celermajer DS; Simonneau G; Humbert M; Hervé P
    Chest; 2016 Feb; 149(2):353-361. PubMed ID: 26134583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.